CN1234387C - Composition possessing lung clearing function and its preparation metod - Google Patents
Composition possessing lung clearing function and its preparation metod Download PDFInfo
- Publication number
- CN1234387C CN1234387C CNB200410000254XA CN200410000254A CN1234387C CN 1234387 C CN1234387 C CN 1234387C CN B200410000254X A CNB200410000254X A CN B200410000254XA CN 200410000254 A CN200410000254 A CN 200410000254A CN 1234387 C CN1234387 C CN 1234387C
- Authority
- CN
- China
- Prior art keywords
- compositions
- stem
- leaf
- fruit
- extracting solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 76
- 210000004072 lung Anatomy 0.000 title claims abstract description 47
- 238000002360 preparation method Methods 0.000 title claims abstract description 43
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 52
- 239000003814 drug Substances 0.000 claims abstract description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 33
- 239000000284 extract Substances 0.000 claims abstract description 30
- 238000010025 steaming Methods 0.000 claims abstract description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 22
- 235000013305 food Nutrition 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 235000013361 beverage Nutrition 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims description 30
- 238000011109 contamination Methods 0.000 claims description 10
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000013355 food flavoring agent Nutrition 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 abstract description 6
- 235000007688 Lycopersicon esculentum Nutrition 0.000 abstract description 4
- 241000227653 Lycopersicon Species 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000000969 carrier Substances 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 description 55
- 239000000243 solution Substances 0.000 description 54
- 230000002685 pulmonary effect Effects 0.000 description 37
- 206010062717 Increased upper airway secretion Diseases 0.000 description 29
- 208000026435 phlegm Diseases 0.000 description 29
- 230000000694 effects Effects 0.000 description 28
- 230000006870 function Effects 0.000 description 27
- 230000003419 expectorant effect Effects 0.000 description 22
- 239000003172 expectorant agent Substances 0.000 description 21
- 230000000391 smoking effect Effects 0.000 description 21
- 206010036790 Productive cough Diseases 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 15
- 208000024891 symptom Diseases 0.000 description 14
- 230000003203 everyday effect Effects 0.000 description 12
- 208000006673 asthma Diseases 0.000 description 11
- 210000000038 chest Anatomy 0.000 description 10
- 235000008429 bread Nutrition 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- DYHOLQACRGJEHX-CYBMUJFWSA-N (-)-Farrerol Natural products C1([C@@H]2OC3=C(C)C(O)=C(C(=C3C(=O)C2)O)C)=CC=C(O)C=C1 DYHOLQACRGJEHX-CYBMUJFWSA-N 0.000 description 8
- DZTRDRPCROOSOG-UHFFFAOYSA-N Matteucinol Natural products C1=CC(OC)=CC=C1C1OC2=C(C)C(O)=C(C)C(O)=C2C(=O)C1 DZTRDRPCROOSOG-UHFFFAOYSA-N 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- DYHOLQACRGJEHX-ZDUSSCGKSA-N farrerol Chemical compound C1([C@H]2OC3=C(C)C(O)=C(C(=C3C(=O)C2)O)C)=CC=C(O)C=C1 DYHOLQACRGJEHX-ZDUSSCGKSA-N 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 8
- 229930182490 saponin Natural products 0.000 description 8
- 150000007949 saponins Chemical class 0.000 description 8
- 241000628997 Flos Species 0.000 description 7
- 239000012141 concentrate Substances 0.000 description 7
- 150000003254 radicals Chemical class 0.000 description 7
- 235000014101 wine Nutrition 0.000 description 7
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 6
- 206010008479 Chest Pain Diseases 0.000 description 6
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 210000002345 respiratory system Anatomy 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 230000001088 anti-asthma Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 206010021079 Hypopnoea Diseases 0.000 description 4
- 101100297651 Mus musculus Pim2 gene Proteins 0.000 description 4
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 4
- 241001597008 Nomeidae Species 0.000 description 4
- 206010035664 Pneumonia Diseases 0.000 description 4
- 208000005946 Xerostomia Diseases 0.000 description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 4
- 206010006451 bronchitis Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 206010013781 dry mouth Diseases 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 239000001630 malic acid Substances 0.000 description 4
- 235000011090 malic acid Nutrition 0.000 description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 4
- 229960002715 nicotine Drugs 0.000 description 4
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 208000024794 sputum Diseases 0.000 description 4
- 210000003802 sputum Anatomy 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 210000003437 trachea Anatomy 0.000 description 4
- 239000000811 xylitol Substances 0.000 description 4
- 235000010447 xylitol Nutrition 0.000 description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 4
- 229960002675 xylitol Drugs 0.000 description 4
- 108010011485 Aspartame Proteins 0.000 description 3
- 241000533849 Gleditsia Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000009636 Huang Qi Substances 0.000 description 3
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000000954 anitussive effect Effects 0.000 description 3
- 239000000924 antiasthmatic agent Substances 0.000 description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 3
- 239000000605 aspartame Substances 0.000 description 3
- 235000010357 aspartame Nutrition 0.000 description 3
- 229960003438 aspartame Drugs 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 235000012970 cakes Nutrition 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 235000019504 cigarettes Nutrition 0.000 description 3
- 235000014510 cooky Nutrition 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000002919 epithelial cell Anatomy 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 229940043353 maltol Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 235000012149 noodles Nutrition 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 235000021395 porridge Nutrition 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 208000009079 Bronchial Spasm Diseases 0.000 description 2
- 206010006482 Bronchospasm Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 241000208125 Nicotiana Species 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000003915 air pollution Methods 0.000 description 2
- PECIYKGSSMCNHN-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=NC=N[C]21.O=C1N(C)C(=O)N(C)C2=NC=N[C]21 PECIYKGSSMCNHN-UHFFFAOYSA-N 0.000 description 2
- 229960003556 aminophylline Drugs 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 239000002440 industrial waste Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 208000030208 low-grade fever Diseases 0.000 description 2
- 201000005296 lung carcinoma Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010006474 Bronchopulmonary aspergillosis allergic Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 208000004430 Pulmonary Aspergillosis Diseases 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 241000863032 Trieres Species 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- IUKLSMSEHKDIIP-BZMYINFQSA-N Verticine Chemical compound C([C@@H]1[C@@H](O)C[C@H]2[C@@H]3CC[C@@H]4[C@]5(C)O)[C@@H](O)CC[C@]1(C)[C@H]2C[C@H]3[C@@H]4CN1[C@H]5CC[C@H](C)C1 IUKLSMSEHKDIIP-BZMYINFQSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 208000006778 allergic bronchopulmonary aspergillosis Diseases 0.000 description 1
- 210000002821 alveolar epithelial cell Anatomy 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 201000008496 endemic goiter Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000003546 flue gas Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 238000005272 metallurgy Methods 0.000 description 1
- -1 metallurgy Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- IUKLSMSEHKDIIP-UHFFFAOYSA-N petine Natural products CC1(O)C2CCC3C4CC(O)C5CC(O)CCC5(C)C4CC3C2CN2C1CCC(C)C2 IUKLSMSEHKDIIP-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 201000009800 pulmonary aspergilloma Diseases 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 201000007048 respiratory system cancer Diseases 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Treatment time (my god) | Produce effects | Recovery from illness | Invalid | Effective percentage (%) | |||
The example number | Obvious effective rate (%) | The example number | Cure rate (%) | The example number | Inefficiency (%) | ||
3 | 135 | 90 | - | - | 0 | 0 | 90 |
7 | 141 | 94 | - | - | 0 | 0 | 94 |
15 | 144 | 96 | - | - | 0 | 0 | 96 |
30 | - | - | 150 | 100 | 0 | 0 | 100 |
Symptom | The pharyngalgia xerostomia | Cough with copious phlegm | Chest distress | Back is ached, is had a headache | Difficult sleeping |
Before the treatment (example) | 144 | 150 | 75 | 135 | 105 |
Treatment back (example) | 3 | 0 | 2 | 4 | 3 |
Effective percentage (%) | 98 | 100 | 97 | 97 | 97 |
Treatment time (my god) | Produce effects | Recovery from illness | Invalid | Effective percentage (%) | |||
The example number | Obvious effective rate (%) | The example number | Cure rate (%) | The example number | Inefficiency (%) | ||
3 | 91 | 91 | - | - | 0 | 0 | 91 |
7 | 93 | 93 | - | - | 0 | 0 | 93 |
15 | 96 | 96 | - | - | 0 | 0 | 96 |
30 | - | - | 100 | 100 | 0 | 0 | 100 |
Symptom | The pharyngalgia xerostomia | Cough with copious phlegm | Chest distress | Back is ached, is had a headache | Difficult sleeping |
Before the treatment (example) | 86 | 100 | 70 | 67 | 76 |
Treatment back (example) | 2 | 0 | 2 | 4 | 5 |
Effective percentage (%) | 98 | 100 | 97 | 94 | 93 |
Treatment time (my god) | Eliminate the phlegm | Cough-relieving | Remove the fuzzy shade of pulmonary | Eliminate pneumonia | ||||
The example number | Effective percentage (%) | The example number | Effective percentage (%) | The example number | Effective percentage (%) | The example number | Effective percentage (%) | |
3 | 20 | 20 | 15 | 15 | 0 | 0 | 0 | 0 |
7 | 50 | 50 | 45 | 45 | 0 | 0 | 15 | 15 |
15 | 85 | 85 | 75 | 75 | 0 | 0 | 70 | 70 |
30 | 95 | 95 | 90 | 90 | Part alleviates 10 | 10 | 92 | 92 |
Treatment time (my god) | Eliminate the phlegm | Cough-relieving | Remove the fuzzy shade of pulmonary | Eliminate pneumonia | ||||
The example number | Effective percentage (%) | The example number | Effective percentage (%) | The example number | Effective percentage (%) | The example number | Effective percentage (%) | |
3 | 70 | 70 | 60 | 60 | 0 | 0 | 10 | 10 |
7 | 85 | 85 | 75 | 75 | 10 | 10 | 45 | 45 |
15 | 90 | 90 | 95 | 95 | 50 | 50 | 65 | 65 |
30 | 98 | 98 | 100 | 100 | 100 | 100 | 100 | 100 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200410000254XA CN1234387C (en) | 2004-01-12 | 2004-01-12 | Composition possessing lung clearing function and its preparation metod |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200410000254XA CN1234387C (en) | 2004-01-12 | 2004-01-12 | Composition possessing lung clearing function and its preparation metod |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1555851A CN1555851A (en) | 2004-12-22 |
CN1234387C true CN1234387C (en) | 2006-01-04 |
Family
ID=34350385
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200410000254XA Expired - Lifetime CN1234387C (en) | 2004-01-12 | 2004-01-12 | Composition possessing lung clearing function and its preparation metod |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1234387C (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101167880B (en) * | 2007-11-20 | 2011-02-02 | 李迺灿 | Lung-clearing composition containing tomato fruit extraction and preparation method thereof |
CN101167881B (en) * | 2007-11-20 | 2011-02-02 | 李迺灿 | Lung-clearing composition containing tomato plant stem extraction and preparation method thereof |
GB0819959D0 (en) * | 2008-10-31 | 2008-12-10 | Provexis Natural Products Ltd | Fruit extracts |
KR20110051876A (en) * | 2009-11-11 | 2011-05-18 | 남종현 | Composition having a detoxification effect on smoking |
KR101092197B1 (en) | 2009-11-11 | 2011-12-13 | 남종현 | Food composition for improving fatty liver which comprises extract of tomato plant as an active component |
CN102696714A (en) * | 2012-05-08 | 2012-10-03 | 王桂琴 | Nutritional flour and preparation method thereof |
CN115316621A (en) * | 2022-07-12 | 2022-11-11 | 无限极(中国)有限公司 | Tomato composition and preparation method and application thereof |
-
2004
- 2004-01-12 CN CNB200410000254XA patent/CN1234387C/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1555851A (en) | 2004-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101822373B (en) | Golden-fungus gingko functional food, preparation method and use thereof | |
CN1223865A (en) | Live triple bifidobacteria preparation and preparing method thereof | |
WO2021114586A1 (en) | Immune response-improving composition, preparation method and application thereof | |
CN101897800B (en) | Traditional Chinese medicine oral liquid for treating mycoplasma gallisepticum infection | |
CN108078975A (en) | Application of the pharmaceutical composition containing eucalyptol, limonene and australene in the drug for preparing treatment upper respiratory tract bacterium infection | |
CN1234387C (en) | Composition possessing lung clearing function and its preparation metod | |
CN104000195B (en) | Clearing lung-heat toxin expelling oral liquid and production method thereof | |
CN1314387C (en) | Children cough and asthma treating Chinese traditional medicine and its preparation | |
CN1449812A (en) | Compound Chinese medicine for treating extensive cancer | |
CN1733146A (en) | Bitter buccal tablet for clearing and moistening throat | |
CN103989173B (en) | Lung nourishing and protecting detoxifying healthy food and production method thereof | |
CN105285381A (en) | Formula feed for cattle and preparation method thereof | |
CN1813819A (en) | Hedgehog hydnum fruiting body or hyphostroma and culture extract and formulation and preparing method | |
CN1405314A (en) | Cryptoporus volvatus fermented product, and its preparation method and application | |
CN113975357B (en) | Traditional Chinese medicine composition for clearing lung, eliminating phlegm, eliminating carbuncle, expelling pus, clearing heat and promoting diuresis and application thereof | |
CN114748603B (en) | Pharmaceutical composition for preventing and treating new coronavirus pneumonia from changing or restoring yang and application thereof | |
CN109663018A (en) | It is a kind of for treating the Chinese medicinal granule and preparation method of silicosis | |
CN1682974A (en) | Chinese medicine preparation for treating acute laryngopharyngitis and its preparing method | |
CN1220515C (en) | Medicine for treating throat disease | |
CN101167881B (en) | Lung-clearing composition containing tomato plant stem extraction and preparation method thereof | |
CN106924371A (en) | A kind of lepidium seed date is tonified the kidney to improve inspiration and controls asthma oral liquid | |
CN103417653A (en) | Veterinary-use compound pure Chinese herbal medicine for treating coccidium and preparation method of oral liquid of same | |
CN101167880B (en) | Lung-clearing composition containing tomato fruit extraction and preparation method thereof | |
CN117018151B (en) | Traditional Chinese medicine composition for treating children cough due to wind-cold evil and application thereof | |
CN107048389A (en) | Lung-moistening and throat-clearing food and preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN CITY TIANJIQUAN HEALTH SERVICES CO., LTD Free format text: FORMER OWNER: LI CAN Effective date: 20061110 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20061110 Address after: 518040, Guangdong, Shenzhen, Futian District, Che Kung Temple, Tian An City digital technology innovation Plaza B, room 1610 Patentee after: Shenzhen Tianjiquan healthcare services Ltd. Address before: 100010, Hutong 9, Yu Fang alley, Beijing, Dongcheng District Patentee before: Li Naican |
|
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Wan Xuetang Document name: Notice of conformity |
|
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN TIANJIQUAN HEALTH TECHNOLOGY GROUP CO., L Free format text: FORMER OWNER: SHENZHEN TIANJIQUAN HEALTH CARE SERVICE CO., LTD. Effective date: 20131217 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 518040 SHENZHEN, GUANGDONG PROVINCE TO: 518047 SHENZHEN, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20131217 Address after: 518047 Guangdong city of Shenzhen province Futian District Shangsha Innovation Technology Park 8 Building 4 floor 401 Patentee after: SHENZHEN TIANJIQUAN HEALTH SCIENCE & TECHNOLOGY GROUP Co.,Ltd. Address before: 518040, Guangdong, Shenzhen, Futian District, Che Kung Temple, Tian An City digital technology innovation Plaza B, room 1610 Patentee before: Shenzhen Tianjiquan healthcare services Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN TIANJIQUAN HENGRENTANG TECHNOLOGY DEVELOP Free format text: FORMER OWNER: SHENZHEN TIANJIQUAN HEALTH TECHNOLOGY GROUP CO., LTD. Effective date: 20140410 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140410 Address after: 518047 Guangdong city of Shenzhen province Futian District Shangsha Innovation Technology Park 8 Building 3 floor Patentee after: Shenzhen Tianjiquan Tongrentang Technology Development Co.,Ltd. Address before: 518047 Guangdong city of Shenzhen province Futian District Shangsha Innovation Technology Park 8 Building 4 floor 401 Patentee before: SHENZHEN TIANJIQUAN HEALTH SCIENCE & TECHNOLOGY GROUP Co.,Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 518047, A building, building 19, Shennan international road, Futian, Shenzhen, Futian District, Shenzhen, Guangdong, 1006, China Patentee after: Shenzhen Tianjiquan Tongrentang Technology Development Co.,Ltd. Address before: 518047 Guangdong city of Shenzhen province Futian District Shangsha Innovation Technology Park 8 Building 3 floor Patentee before: Shenzhen Tianjiquan Tongrentang Technology Development Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211103 Address after: 518026 201, Jinglian garden, No. 32, Jingtian East Road, Jinghua community, Lianhua street, Futian District, Shenzhen, Guangdong Province Patentee after: SHENZHEN TIANJIQUAN HEALTH SCIENCE & TECHNOLOGY GROUP Co.,Ltd. Address before: 518047 19 / F, building a, Shenzhen International Innovation Center (Futian science and Technology Plaza), 1006 Shennan Avenue, Futian District, Shenzhen City, Guangdong Province Patentee before: Shenzhen Tianjiquan Tongrentang Technology Development Co.,Ltd. |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20060104 |